Page last updated: 2024-12-07

9-aminoellipticine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

9-Aminoellipticine is a synthetic ellipticine derivative that exhibits potent antitumor activity. It is an intercalating agent that binds to DNA, inhibiting DNA replication and transcription. The compound's synthesis involves several steps starting from ellipticine, a natural product isolated from the plant *Ochrosia grandiflora*. 9-aminoellipticine has shown promising preclinical results against various types of cancer, including leukemia, lung cancer, and breast cancer. It is studied because of its unique mechanism of action and its potential as a novel anticancer drug. However, its clinical development has been limited due to toxicity concerns.'

9-aminoellipticine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID99172
SCHEMBL ID3342543
MeSH IDM0115579

Synonyms (16)

Synonym
nsc 191345
icig 1089
6h-pyrido(4,3-b)carbazol-9-amine, 5,11-dimethyl-
brn 0754366
5,11-dimethyl-6h-pyrido(4,3-b)carbazol-9-amine
ccris 6481
6h-pyrido[4,3-b]carbazol-9-amine, 5,11-dimethyl-
nsc191345
nsc-191345
9-aminoellipticine
54779-53-2
5,11-dimethyl-6h-pyrido[4,3-b]carbazol-9-amine
SCHEMBL3342543
DTXSID30970101
aminoellipticine, 9-
626V38C3NM
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (53.33)18.7374
1990's7 (46.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.65 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.43 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]